HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gervasio A Lamas Selected Research

Chelation Therapy (Therapy, Chelation)

1/2022Chelation Therapy in Patients With Cardiovascular Disease: A Systematic Review.
11/2020Differential Outcomes With Edetate Disodium-Based Treatment Among Stable Post Anterior vs. Non-Anterior Myocardial Infarction Patients.
1/2020Possible differential benefits of edetate disodium in post-myocardial infarction patients with diabetes treated with different hypoglycemic strategies in the Trial to Assess Chelation Therapy (TACT).
1/2020Urinary Metal Levels after Repeated Edetate Disodium Infusions: Preliminary Findings.
1/2019The effect of EDTA-based chelation on patients with diabetes and peripheral artery disease in the Trial to Assess Chelation Therapy (TACT).
1/2018Chelation therapy to prevent diabetes-associated cardiovascular events.
12/2016Chronic Toxic Metal Exposure and Cardiovascular Disease: Mechanisms of Risk and Emerging Role of Chelation Therapy.
8/2016Chelation therapy to treat atherosclerosis, particularly in diabetes: is it time to reconsider?
2/2016Edetate Disodium-Based Treatment for Secondary Prevention in Post-Myocardial Infarction Patients.
1/2016Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gervasio A Lamas Research Topics

Disease

41Myocardial Infarction
10/2022 - 07/2004
25Infarction (Infarctions)
06/2014 - 11/2004
18Heart Failure
10/2013 - 06/2003
14Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 07/2004
9Atherosclerosis
01/2021 - 10/2002
6Stroke (Strokes)
01/2018 - 07/2004
4Sick Sinus Syndrome
09/2014 - 06/2003
4Coronary Disease (Coronary Heart Disease)
07/2014 - 10/2002
4Ischemia
04/2009 - 09/2007
4Ventricular Fibrillation
05/2008 - 09/2007
3Peripheral Arterial Disease
01/2022 - 01/2019
3Diabetes Mellitus
01/2014 - 07/2004
3Atrial Fibrillation
12/2013 - 06/2003
3Hypertension (High Blood Pressure)
03/2012 - 10/2002
3Reperfusion Injury
11/2008 - 09/2007
3Left Ventricular Dysfunction
11/2004 - 06/2004
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2019 - 03/2012
2Mitral Valve Insufficiency (Mitral Regurgitation)
01/2013 - 08/2005
2Aortic Valve Stenosis (Aortic Stenosis)
06/2012 - 01/2012
2Asphyxia (Suffocation)
11/2008 - 04/2008
2Heart Arrest (Cardiac Arrest)
04/2008 - 01/2002
2Cardiomyopathies (Cardiomyopathy)
11/2002 - 07/2002
1Prehypertension
01/2016
1Isolated Systolic Hypertension
01/2016
1Heart Block
06/2015
1Heart Diseases (Heart Disease)
05/2015
1Atrioventricular Block
09/2014
1Endocarditis
05/2014
1Sepsis (Septicemia)
05/2014
1Acute Kidney Injury (Acute Renal Failure)
12/2013
1Chronic Renal Insufficiency
12/2013
1Non-ST Elevated Myocardial Infarction
04/2013
1Chronic Obstructive Pulmonary Disease (COPD)
10/2012
1Renal Insufficiency (Renal Failure)
10/2012
1Thrombosis (Thrombus)
04/2012
1Respiratory Sounds (Crackle)
03/2012
1Hemorrhage
08/2011
1Ventricular Remodeling
03/2011
1Shock
11/2008

Drug/Important Bio-Agent (IBA)

8Edetic Acid (EDTA)FDA Link
01/2022 - 03/2013
8MetalsIBA
01/2021 - 06/2012
7CadmiumIBA
01/2022 - 12/2014
4CreatinineIBA
07/2014 - 10/2012
4Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
06/2012 - 06/2004
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2018 - 09/2005
3Captopril (Capoten)FDA LinkGeneric
11/2004 - 07/2004
2SolutionsIBA
10/2022 - 07/2014
2Chelating AgentsIBA
01/2022 - 12/2014
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2020 - 10/2002
2Insulin (Novolin)FDA Link
01/2020 - 11/2004
2XenobioticsIBA
12/2014 - 08/2014
2Indicators and Reagents (Reagents)IBA
10/2012 - 05/2005
2ProstaglandinsIBA
05/2008 - 01/2008
2Angiotensin Receptor AntagonistsIBA
09/2005 - 11/2004
2Biological ProductsIBA
09/2005 - 07/2004
2LipidsIBA
10/2004 - 10/2002
2Brain Natriuretic Peptide (Natrecor)FDA Link
11/2002 - 07/2002
1MineralsIBA
10/2022
1Acetic Acid (Vinegar)FDA LinkGeneric
10/2022
1ethylenediamine (ethylenediamine dihydroiodide)FDA Link
10/2022
1CalciumIBA
01/2022
1Divalent CationsIBA
01/2022
1DiaminesIBA
01/2018
1AcidsIBA
01/2018
1Advanced Glycation End ProductsIBA
01/2018
1ethyleneIBA
01/2018
1VitaminsIBA
01/2018
1Heavy MetalsIBA
01/2016
1salicylhydroxamic acid (SHAM)IBA
01/2016
1MercuryIBA
12/2014
1Environmental Pollutants (Pollutants, Environmental)IBA
12/2014
1ArsenicIBA
12/2014
1Dichlorodiphenyldichloroethane (DDD)IBA
09/2014
1SmokeIBA
03/2012
1Fibrinolytic Agents (Antithrombotic Agents)IBA
03/2010
1Troponin IIBA
11/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2008
1Peroxidase (Myeloperoxidase)IBA
11/2008
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
05/2008

Therapy/Procedure

32Therapeutics
01/2020 - 10/2002
25Percutaneous Coronary Intervention
06/2014 - 12/2006
18Chelation Therapy (Therapy, Chelation)
01/2022 - 03/2013
5Sternotomy
05/2014 - 06/2011
5Cardiopulmonary Resuscitation (CPR)
05/2008 - 01/2002
4Length of Stay
05/2014 - 11/2010
3Secondary Prevention
12/2016 - 12/2014
3Stents
06/2012 - 09/2009
2Drug Therapy (Chemotherapy)
01/2021 - 08/2005
2Patient Readmission
11/2010 - 11/2008
2Resuscitation
11/2008 - 04/2008
2Induced Heart Arrest (Cardioplegia)
04/2008 - 01/2008
1Spinal Manipulation
01/2016
1Cardiac Resynchronization Therapy
06/2015
1Off-Label Use
09/2014
1Minimally Invasive Surgical Procedures
12/2013
1Thoracotomy
01/2013
1Drug-Eluting Stents
06/2012
1Prostheses and Implants (Prosthesis)
01/2012
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
06/2011
1Artificial Respiration (Mechanical Ventilation)
11/2008